EUVIMEDEUVIMED entdecken
Crossref

Inflammatory profile in patients with rheumatoid arthritis and sarcopenia

Mariel Lozada-Mellado, Luis Llorente, Andrea Hinojosa-Azaola, Midori Ogata-Medel, Raymundo David Valdez-Echeverría, Ana Rosalía Lira-Reyes, Lilia Castillo-Martínez

Clinical Rheumatology · 2024-06 · 43 (6) · 1865-1870

DOI: 10.1007/s10067-024-06974-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 26.04.2024. Verfasst von Mariel Lozada-Mellado und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Mexico City, Mexico. Hauptthemen laut MEDLINE: Sarcopenia, Arthritis, Rheumatoid, Inflammation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: CONAHCYT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Sarcopenia is characterized by the loss of muscle mass and strength associated with aging; however, individuals with chronic diseases are at risk at the early stages. In rheumatoid arthritis (RA), sustained chronic inflammation influences muscle deterioration. It may expedite the development of sarcopenia, which has been linked to physical disability, cardiovascular events, disease activity of RA, and premature death. We aimed to compare the inflammatory profiles of patients with RA with and without sarcopenia. METHODS: This cross-sectional study involved 165 women with RA. Sarcopenia was diagnosed according to criteria established by the European Working Group on Sarcopenia in Older People. To assess the inflammatory profile, concentrations of cytokines such as EGF, IL-17, IL-1α, IL-1β, IL-6, TNFα, TNFβ, and creatine kinase (CK) were measured. RESULTS: The prevalence of sarcopenia was 15.8% (95% CI: 8.9-18.2). The median age of patients with sarcopenia was 59.5 years (49.8-65.3), compared to 50 years (43-59 years) p = 0.001. The disease duration was also longer in patients with sarcopenia, 21 years (15-30), compared to those without sarcopenia, 13 years (7.3-20) p = 0.001. The inflammatory profile differed between patients with and without sarcopenia, revealing that the cytokines IL-1α, IL-6, and TNFβ concentrations were significantly higher (p < 0.05) in patients with sarcopenia, adjusted for BMI, age, and disease duration. CONCLUSION: Patients with RA and sarcopenia were older and exhibited longer disease duration and higher levels of inflammatory cytokines compared to those without sarcopenia. These findings suggest potential implications for clinical outcomes. Key Points • The prevalence of sarcopenia in women with rheumatoid arthritis was 15.8% (95% CI, 8.9-18.2). • Levels of IL-1α, IL-6, and TNFβ cytokines were significantly higher in women with rheumatoid arthritis and sarcopenia compared with those without sarcopenia, adjusted for BMI, age, and disease duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaArthritis, RheumatoidInflammationHumansFemaleMiddle AgedCross-Sectional StudiesAgedCytokinesAdultPrevalence

Substanzen

Cytokines

Autor:innen und Institutionen

  • Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Clinical Nutrition Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, 14080, Mexico City, Mexico.
  • Deparment of Central Laboratory, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Clinical Nutrition Service, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, 14080, Mexico City, Mexico. cam7125@gmail.com.

Förderung

  • CONAHCYT

Zitieren

APA

Lozada-Mellado, M., Llorente, L., Hinojosa-Azaola, A., Ogata-Medel, M., Valdez-Echeverría, R. D., Lira-Reyes, A. R., & Castillo-Martínez, L. (2024). Inflammatory profile in patients with rheumatoid arthritis and sarcopenia. Clinical Rheumatology, 43(6), 1865-1870. https://doi.org/10.1007/s10067-024-06974-9

Vancouver

Lozada-Mellado M, Llorente L, Hinojosa-Azaola A, Ogata-Medel M, Valdez-Echeverría RD, Lira-Reyes AR, et al. Inflammatory profile in patients with rheumatoid arthritis and sarcopenia. Clinical Rheumatology. 2024;43(6):1865-1870. doi:10.1007/s10067-024-06974-9

BibTeX
@article{LozadaMellado2024,
  author = {Lozada-Mellado, Mariel and Llorente, Luis and Hinojosa-Azaola, Andrea and Ogata-Medel, Midori and Valdez-Echeverría, Raymundo David and Lira-Reyes, Ana Rosalía and Castillo-Martínez, Lilia},
  title = {Inflammatory profile in patients with rheumatoid arthritis and sarcopenia},
  journal = {Clinical Rheumatology},
  year = {2024},
  volume = {43},
  number = {6},
  pages = {1865--1870},
  doi = {10.1007/s10067-024-06974-9}
}
Kostenlos starten →